Anterix CEO Scott Lang sells 15,000 shares

Anterix’s president and CEO reported a 15,000‑share open‑market sale at $80, leaving 26,470 shares held directly.

Rhea-AI Filing Summary

Anterix Inc. (ATEX) reported that President and CEO, and director, Scott A. Lang sold 15,000 shares of common stock on September 21, 2026 in a sale characterized as an open market or private transaction at $80.00 per share. Following this transaction, he directly holds 26,470 shares of Anterix common stock, and no Rule 10b5-1 trading plan is reported in connection with this sale.

Insider Trade Summary

Net Seller: 15,000 shares

Net Sell 1 txn

Insider Lang Scott A.

Role President and CEO

Sold 15,000 shs ($1.20M)

Type	Security	Shares	Price	Value
Sale	Common Stock	15,000	$80.00	$1.20M

Holdings After Transaction: Common Stock — 26,470 shares (Direct)

Key Figures

Shares sold: 15,000 shares Sale price: $80.00 per share Shares held after transaction: 26,470 shares

3 metrics

Shares sold 15,000 shares Common stock sale reported for September 21, 2026

Sale price $80.00 per share Price for the 15,000 Anterix common shares sold

Shares held after transaction 26,470 shares Direct ownership of Scott A. Lang following the sale

Key Terms

open market or private transaction, Rule 10b5-1 trading plan

2 terms

open market or private transaction financial

"Sale in open market or private transaction"

Rule 10b5-1 trading plan regulatory

"no Rule 10b5-1 trading plan is reported"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Anterix (ATEX) disclose for Scott A. Lang?

Anterix disclosed that Scott A. Lang, its President, CEO, and director, sold 15,000 shares of common stock on September 21, 2026 in an open market or private transaction at $80.00 per share.

How many Anterix (ATEX) shares does Scott A. Lang hold after this Form 4 sale?

After the reported transaction, Scott A. Lang directly holds 26,470 shares of Anterix common stock, as stated in the Form 4 filing.

At what price were the Anterix (ATEX) shares sold in this Form 4 filing?

The 15,000 Anterix shares reported in the Form 4 were sold at a price of $80.00 per share in a transaction described as an open market or private sale.

Was the Anterix (ATEX) insider sale made under a Rule 10b5-1 trading plan?

No. The Form 4 indicates that no Rule 10b5-1 trading plan is reported in connection with this 15,000-share sale by Scott A. Lang.

What role does Scott A. Lang hold at Anterix (ATEX) in this Form 4?

Scott A. Lang is identified as both a director and an officer of Anterix, serving as President and CEO, in the Form 4 reporting this insider transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/22/2026 - 04:12 PM Accepted by SEC EDGAR 09/22/2026 - 04:12 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lang Scott A.

(Last) (First) (Middle)

3 GARRET MOUNTAIN PLAZA

SUITE 401

(Street)

WOODLAND PARK NEW JERSEY 07424

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Anterix Inc. [ ATEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/21/2026		S		15,000	D	$80	26,470	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	s/ Gena L. Ashe, Attorney-in-Fact	09/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)